US 8999380B2
· Bancel et al.
· 2015
[cited by applicant]
US 20140032186A1
· Gustafsson et al.
· 2014
[cited by applicant]
US 20140196176A1
· Heintz
· 2014
[cited by examiner]
US 20150111955A1
· High
· 2015
[cited by examiner]
DE 10156121A1
· 2003
[cited by applicant]
WO WO2003052051A2
· 2003
[cited by applicant]
WO WO2011126808A2
· 2011
[cited by applicant]
WO WO2013049493A1
· 2013
[cited by applicant]
WO WO2015012924A2
· 2015
[cited by applicant]
WO WO2016097218A1
· 2016
[cited by applicant]
WO WO2016097219A1
· 2016
[cited by examiner]
WO WO2016181123A1
· 2016
[cited by applicant]
WO WO2017100676A1
· 2017
[cited by applicant]
WO WO2018126116A1
· 2018
[cited by applicant]
WO WO2020102723A1
· 2020
[cited by applicant]
WO WO2020142653A1
· 2020
[cited by applicant]
Shanmugavel et al. Metallomics, 2017, 9, 981-988 (Year: 2017).
[cited by examiner]
Hasan et al. J Biol Chem. Aug. 16, 2012;287(43):36041-36050 (Year: 2012).
[cited by examiner]
Leng et al. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B; Human Gene Therapy 30 (12), 2019, 1494-1504 (Year: 2019).
[cited by examiner]
Grote et al, JCat: a novel tool to adapt codon usage of a target gene to its potential expression host, Nucleic Acids Research 33:W526-W531; doi:10.1093/nar/gki376, 2005 (Year: 2005).
[cited by examiner]
Daniel et al, ATGme: Open-source web application for rare codon identification and custom DNA sequence optimization, BMC Bioinformatics 16: 303, 6 pages, doi. 10.1186/s12859-015-0743-5; 2015 (Year: 2015).
[cited by examiner]
Fumoto et al, Targeted Gene Delivery: Importance of Administration Routes, INTECH, Novel Gene Therapy Approaches, p. 3-31; editors Wei and Good, publisher Books on Demand, 2013 (Year: 2013).
[cited by examiner]
Daya et al, Gene Therapy Using Adeno-Associated Virus Vectors, Clin. Microbiol. Rev. 21(4): 583-593, 2008 (Year: 2008).
[cited by examiner]
Tian et al, Aerosol Inhalation-mediated Delivery of an Adeno-associated Virus 5-expressed Antagonistic Interleukin-4 Mutant Ameliorates Experimental Murine Asthma, Archives of Medical Research 50: 384-392, 2019 (Year: 2…
[cited by examiner]
Mingozzi and High, Immune responses to AAV vectors: overcoming barriers to successful gene therapy, Blood 122(1): 23-36, 2013 (Year: 2013).
[cited by examiner]
Kattenhorn et al, Adeno-Associated Virus Gene Therapy for Liver Disease, Human Gene Therapy 27(12): 947-961, Nov. 28, 2016 (Year: 2016).
[cited by examiner]
Perrin, Make mouse studies work, Nature (507): 423-425, 2014 (Year: 2014).
[cited by examiner]
Greenberg, Gene Therapy for heart failure, Trends in Cardiovascular Medicine 27: 216-222, 2017 (Year: 2017).
[cited by examiner]
Maguire et al, Viral vectors for gene delivery to the inner ear, Hearing Research 394: e107927, 13 pages, doi.org/10.1016/j.heares.2020.107927, 2020 (Year: 2020).
[cited by examiner]
Tobias, Mouse Study Used in Research, Multiple Sclerosis News Today, multiplesclerosisnewstoday.com/news-posts/2023/09/08/lets-not-get-overexcited-about-any-mice-study-used-research/; Sep. 8, 2023; (Year: 2023).
[cited by examiner]
Bartee et al., “The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation,” Biochemistry, 2009, 48(24): 5573-5581.
[cited by applicant]
Bernard et al., “Hepatic lesions in 90 captive nondomestic felids presented for autopsy,” Vet Pathol. 2015, 52(2): 369-376.
[cited by applicant]
Braiterman et al., “Communication between the N and C termini is required for copper-stimulated Ser/Thr phosphorylation of Cu(I) -ATPase (ATP7B),” Journal of Biological Chemistry, 2015, 290(14): 8803-8819.
[cited by applicant]
Buiakova et al., “Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation,” Hum Mol Genet., 1999, 8(9),1665-71.
[cited by applicant]
Calcedo et al., “Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses,” J Infect Dis., 2009, 199(3), 381-90.
[cited by applicant]
Cardone et al., “Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery”, Hum Mol Genet. 2006, 15(7): 1225-1236.
[cited by applicant]
Coronado et al., “The Jackson toxic milk mouse as a model for copper loading,” Mamm Genome, 2001, 12(10), 793-795.
[cited by applicant]
Davidoff et al., “Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway,” Blood, 2003, 102(2), 480-488.
[cited by applicant]
European Association for the Study of the Liver, EASL Clinical Practice Guidelines: Wilson's disease, J Hepatol. 2012, 56(3):671-85.
[cited by applicant]
Gao et al., “Adeno-associated viruses undergo substantial evolution in primates during natural infections,” Proc Natl Acad Sci USA, 2003, 13, 100(10), 6081-6.
[cited by applicant]
Gao et al., “Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates,” Mol Ther., 2006, 13(1), 77-87.
[cited by applicant]
Gourdon et al., “Structural models of the human copper P-type ATPases ATP7A and ATP7B,” Biol Chem. 2012, 393(4), 205-16.
[cited by applicant]
Gray et al., “Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load,” PLoS One, 2012, 7(6):e38327 (10 pages).
[cited by applicant]
Greig et al., “A Gene Therapy Approach to Improve Copper Metabolism and Prevent Liver Damage in a Mouse Model of Wilson Disease,” Human Gene Therapy Clin Dev. 2019, 30(1): 29-39.
[cited by applicant]
Greig et al., “Characterization of adeno-associated viral vector-mediated human Factor VIII gene therapy in hemophilia A Mice,” Human Gene Therapy 2017, 28(5), 392-402.
[cited by applicant]
Grimm et al., “Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2,” Gene Ther., 1999, 6(7), 1322-30.
[cited by applicant]
Hasan et al., “Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-golgi network,” Journal of Biological Chemistry, 2012, 287(43):36041-36050.
[cited by applicant]
Huster et al., “Consequences of copper accumulation in the livers of the Atp7b
[cited by applicant]
Huster et al., “The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein,” J Biol Chem., 2003, 278(34), 32212-8.
[cited by applicant]
International Search Report and Written Opinion for corresponding International Application No. PCT/US2020/012131, dated Mar. 30, 2020.
[cited by applicant]
Irani et al., “Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans cinnamon rats modeling Wilson's disease,” Mol Ther., 2001, 3(3), 302-9.
[cited by applicant]
Lock et al., “Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR,” Hum Gene Ther Methods, 2014, 25(2), 115-25.
[cited by applicant]
Lock et al., “Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale,” Hum Gene Ther., 2010, 21(10), 1259-71.
[cited by applicant]
Lutsenko et al., “Function and regulation of human copper-transporting ATPases,” Physiol Rev., 2007, 87(3), 1011-46.
[cited by applicant]
McIntosh et al., “Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant,” Blood, 2013, 121(17), 3335-44.
[cited by applicant]
McMillin et al., “Direct measurement of free copper in serum or plasma ultrafiltrate,” Am J Clin Pathol., 2009, 131(2), 160-5.
[cited by applicant]
Michalczyk et al., “ATP7B expression in human breast epithelial cells is mediated by lactational hormones,” J Histochem Cytochem., 2008, 56(4), 389-99.
[cited by applicant]
Miyatake et al., “Transcriptional targeting of herpes simplex virus for cell-specific replication,” J Virol., 1997, 71(7), 5124-32.
[cited by applicant]
Murillo et al., “Long-term metabolic correction of Wilson's disease in a murine model by gene therapy,” J Hepatol, 2016, 64(2), 419-426.
[cited by applicant]
Petrukhin et al., “Mapping, cloning and genetic characterization of the region containing the Wilson disease gene,” Nat Genet. 1993, 5(4), 338-43.
[cited by applicant]
Roberts EA and Schilsky ML, American Association for Study of Liver D. Diagnosis and treatment of Wilson disease: an update, Hepatology., 2008, 47(6), 2089-111.
[cited by applicant]
Roybal et al., “Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease,” Gene Ther., 2012, 19(11), 1085-94.
[cited by applicant]
Safaei et al., “The role of metal binding and phosphorylation domains in the regulation of cisplatin-induced trafficking of ATP7B,” Metallomics, 2013, 5(8), 964-72 (17 pages).
[cited by applicant]
Sandig et al., “HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene,” Gene Ther., 1996, 3(11), 1002-9.
[cited by applicant]
Sasaki et al., “The gene responsible for LEC hepatitis, located on rat chromosome 16, is the homolog to the human Wilson disease gene,” Biochem Biophys Res Commun., 1994, 202(1), 512-8.
[cited by applicant]
Schosinsky et al., “Measurement of Ceruloplasmin From its Oxidase Activity in Serum by Use of O-dianisidine Dihydrochloride,” Clin Chem, 1974, 20(12), 1556-63.
[cited by applicant]
Shanmugavel et al., “Copper relay path through the N-terminus of Wilson disease protein, ATP7B,” Metallomics, 2019, 11(9): 1472-1480.
[cited by applicant]
Shanmugavel et al., “Probing functional roles of Wilson disease protein (ATP7B) Copper-binding domains in yeast,” Metallomics, 2017, 9(7), 981-988.
[cited by applicant]
Smedley et al., “Copper-associated hepatitis in Labrador retrievers,” Vet Pathol. 2009, 46(3), 484-90.
[cited by applicant]
Sommer et al., “Quantification of adeno-associated virus particles and empty capsids by optical density measurement,” Mol Ther., 2003, 7(1), 122-8.
[cited by applicant]
Stromeyer FW and Ishak KG, Histology of the liver in Wilson's disease: a study of 34 cases, Am J Clin Pathol., 1980, 73(1), 12-24.
[cited by applicant]
Tanzi et al., “The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene,” Nat Genet. 1993, 5(4), 344-50.
[cited by applicant]
Terada K and Sugiyama T, The Long-Evans Cinnamon rat: an animal model for Wilson's disease, Pediatr Int., 1999, 41(4), 414-8.
[cited by applicant]
Theophilos et al., “The toxic milk mouse is a murine model of Wilson disease,” Hum Mol Genet, 1996, 5(10), 1619-1624.
[cited by applicant]
Thompson et al., “A comprehensive comparison of multiple sequence alignments,” Nucleic Acids Res., 1999, 27(13), 2682-90.
[cited by applicant]
Thornburg et al., “Hereditary copper toxicosis in West Highland white terriers,” Vet Pathol., 1986, 23(2), 148-54.
[cited by applicant]
Toole et al., “A large region (approximately equal to 95 kDa) of human factor Vlll is dispensable for in vitro procoagulant activity,” Proc Natl Acad Sci USA, 1986, 83(16), 5939-42.
[cited by applicant]
Ward et al., “Codon optimization of human factor VIII cDNAs leads to high-level expression,” Blood, 2011, 117(3), 798-807.
[cited by applicant]
Wobus et al., “Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infectio…
[cited by applicant]
Wu et al., “Effect of genome size on AAV vector packaging,” Mol Ther., 2010, 18(1), 80-6.
[cited by applicant]
Wu et al., “Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose,” Mol Ther., 2008, 16(2), 280-9.
[cited by applicant]
Chuah et al. (2014) “Liver-Specific Transcriptional Modules Identified by Genome-Wide in Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates” Molecular Therapy 22(9):1605-1613.
[cited by applicant]
Dong et al. (1996) “Quantitative analysis of the packaging capacity of recombinant adeno-associated virus,” Hum Gene Ther. 7(17):2101-12 (31 pages).
[cited by applicant]
Harding et al. (2004) “Intravenous administration of an AA V-2 vector for the expression of factor IX in mice and a dog model of hemophilia B,” Gene Ther. 11(2):204-13.
[cited by applicant]
Loeb et al. (1999) “Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy,” Hum Gene Ther. 10(14):…
[cited by applicant]
McFarland et al. (2006) “Evaluation of a novel short polyadenylation signal as an alternative to the SV40 polyadenylation signal,” Plasmid 56(1):62-7.
[cited by applicant]
Murillo et al. (2016) “Improvement of Gene Therapy for Wilson Disease,” Molecular Therapy 24(1)S64.
[cited by applicant]
NCBI GenBank Accession No. U03464.1, Human P-type ATPase ATP7B mRNA, complete cds, Apr. 23, 1997 (3 pages).
[cited by applicant]
NCBI Reference Sequence: NP_000044.2 copper-transporting ATPase 2 isoform a [
[cited by applicant]
Samadani et al. (1996) “Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3 beta isoform,” Gene Expr. 6(1):23-33.
[cited by applicant]
Shanmugavel et al., “Probing functional roles of Wilson disease protein (ATP7B) Copper-binding domains in yeast,” Metallomics, 2017, 9(7), 981-988, supplemental information (17 pages).
[cited by applicant]
Valencia et al. (2008) Splicing promotes rapid and efficient mRNA export in mammalian cells, Proc Natl Acad Sci U S A. 105(9):3386-91.
[cited by applicant]
Yan et al. (2012) “Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern,” Gene 506(2):289-94.
[cited by applicant]